10-Q · May 7, 2026
CHMI's Q1 2026 performance showed a significant increase in revenue, reporting $4,456,000 compared to $3,210,000 in Q4 2025, while grappling with a diluted EPS of -$0.05 against an expected $0.12. The segment…
Earnings analysis · 10-Q
CHMI earnings analysis
Filed August 10, 2026 · Our reading of the company's report
The latest report
Q2 2026 reported EPS of $0.15 exceeded the $0.13 estimate and improved from a $0.05 diluted loss in Q1, while revenue of $4.736 million beat the $4.1 million estimate. However, the filing does not provide sufficient Q2…
Read full summary
Q2 2026 reported EPS of $0.15 exceeded the $0.13 estimate and improved from a $0.05 diluted loss in Q1, while revenue of $4.736 million beat the $4.1 million estimate. However, the filing does not provide sufficient Q2 income-statement detail to calculate gross or operating margins, free cash flow, or segment performance. The most material development is the pending MITT merger, which introduces a fixed 0.3063x exchange ratio, a potential 4.0% termination fee, a $0.10 dividend cap, and operating restrictions while the transaction remains pending.
Reported figures
- Earnings per share
- $0.15
What stood out
-
EPS Rebounded to $0.15
Q2 2026 EPS was $0.15 versus a $0.13 estimate, a $0.02 beat. EPS also improved from a diluted loss of $0.05 in Q1 2026.
-
Revenue Beat Estimates
Reported Q2 revenue was $4.736 million, exceeding the $4.1 million estimate by $0.636 million, or approximately 15.5%.
-
RMBS Portfolio Expanded
The RMBS portfolio, net of swaps, was $862.032 million at June 30, 2026, compared with $852.643 million at December 31, 2025.
-
Counterparty Exposure Limited
Repurchase-agreement counterparty exposure did not exceed 5% of the Company's equity as of June 30, 2026, limiting concentration to any single counterparty.
What to watch
-
Fixed Merger Consideration
The pending merger has a fixed 0.3063x exchange ratio and includes $0.41 per share in cash from MITT plus $0.52 per share from MITT Manager. A decline in MITT's share price before closing would reduce the market value received by CHMI shareholders.
-
Merger Completion Risk
Merger completion requires multiple conditions, including stockholder approvals, an effective Form S-4 registration statement, NYSE listing approvals, and regulatory approvals. If terminated in specified circumstances, CHMI may owe a termination fee equal to 4.0% of equity value.
-
Merger Constraints on Operations
During the merger pendency, quarterly common-stock dividends are capped at $0.10 per share, and merger covenants may restrict asset transactions, indebtedness, equity issuance, and capital expenditures without MITT's consent.
-
Interest-Rate Sensitivity
A hypothetical 0.75% parallel increase in interest rates would reduce estimated RMBS fair value by $12.601 million, or 1.46%, from the June 30, 2026 base value of $862.032 million.
-
MSR Valuation Sensitivity
MSR fair value was $211.105 million at June 30, 2026. A 10% increase in the voluntary prepayment rate would reduce estimated value by $5.792 million, while a 10% increase in the discount rate would reduce it by $9.247 million.
-
Funding and Liquidity Risk
Management states that weak financial, residential mortgage, or broader economic markets could make lenders unwilling or unable to provide financing or could increase financing costs. The company expects continued reliance on repurchase agreements for RMBS and bank loans secured by MSRs.
Management's outlook
No explicit quantitative revenue or EPS guidance was provided in the extracted 10-Q. Management states it expects to continue financing RMBS with repurchase agreements and MSRs with bank loans, and may use additional MSR financing, warehouse facilities, securitizations, and equity or debt issuance.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.